Delays in Thrombolytic Therapy in Acute Myocardial Infarction: An Audit from the East Coast of Peninsular Malaysia

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 3, 1997, Pages 285-289

  Loke, Y K ^a   Hwang, S L ^a   Tan, M H ^a  

^a Hospital Kuala Terengganu   (Malaysia)

Author keywords

Clinical protocols; Emergencies; Time factors

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CORONARY CARE UNIT; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALAYSIA; MEDICAL AUDIT; TIME;

CLINICAL PROTOCOLS; CORONARY CARE UNITS; HUMANS; MALAYSIA; MEDICAL AUDIT; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0031132761     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i:397-401.
2. 1SIS-2 (Second International Study of Infarct Survival) Collaborative Group. A multicentre randomized trial of intravenous streptokinase and aspirin in acute myocardial infarction. Lancet 1988; ii:349-60.
3. FIT Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overviews of early mortality and major morbidity results from all randomized trials of more than 100 patients. Lancet 1994; 343:311-9.
4. Rawles J. Magnitude of benefit from earlier thrombolytic therapy in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT). BMJ 1996; 312:212-6.
5. Terengganu's Vital Statistics. Wings of Gold 1996, May:81
6. Rose G A, Blackburn H, editors. Cardiovascular Survey Methods. 2nd ed. Geneva: World Health Organisation, 1982.
7. Rawles J M, Haites N E. Patient and general practitioner delays in acute myocardial infarction BMJ 1988; 296:882-5.
8. Maynard C, Weaver W D, Lambrew C, Bowlby L J, Rogers W J, Rubison R M. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Am J Cardiol 1995; 76:548-52.
9. Quek D K L, Ong S B L, Lim L Y Myocardial infarction, circadian rhythm and delay in hospital admission Med J Malaysia 1989; 44:14-22.
10. Ho M T, Eisenberg M S, Litwin P E, Schaeffer S M, Damon S K. Delay between onset of chest pain and seeking medical care, the effect of public education Ann Emerg Med 1989; 18:727-31
11. Pell A C H, Miller H C, Robertson C E, Fox K A A. Effect of "fast track' admission for acute myocardial infarction on delay to thrombolysis BMJ 1992; 304:83-7.
12. Birkhead J S, Chamberlain D A, Griffith B E, Heber M E, Smythe H C, Thomas RD, et al. Time delays in provision of thrombolytic therapy in six district hospitals. BMJ 1992; 305:445-8.
13. Sharkey S W, Bruneete D D, Ruiz E, Hession W T, Wysham D G, Goldenberg I F, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA 1989; 262.3171-4.
14. Kereiakes D J, Weaver W D, Anderson J L, Feldman T, Gibler B, Aufderheide T, et al. Time delays in the diagnosis and treatment of acute myocardial infarction. a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project Am Heart J 1990; 120:773-80
15. Gonzalez E R, Jones L A, Omato J P, Bleecker G C, Strauss M J (Virginia Thrombolytic Study Group). Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy. a multicenter prospective assessment. Ann Emerg Med 1992; 21:1215-21.